1Cell.Ai at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

1Cell.Ai brings 2 presentations to ISLB 2026 in Madrid. Its work uses blood tests to find treatable molecular targets in cancer. One study assesses homologous recombination deficiency from blood to identify patients eligible for DNA repair-targeted therapies, and another maps actionable biomarkers in small cell lung cancer.

OrganizationISLB 2026 Attendance
1Cell.Ai
Cupertino, CA
1cell.ai
Diagnostics & testing labs
Precision oncology testing company combining single-cell multi-omics of circulating tumor cells with AI, with a clinical laboratory in India.
Poster
Poster

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from 1Cell.Ai

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction